ProCE Banner Activity

How I Manage Low-Level Viremia in Patients Receiving HBV Therapy

Clinical Thought
Patients with low levels of HBV DNA are at greater risk of HCC, particularly those with cirrhosis. Read how I evaluate for causes of low-level viremia and manage patients in this situation.

Released: September 24, 2018

Expiration: September 23, 2019

No longer available for credit.

Share

Faculty

Robert S. Brown, Jr.

Robert S. Brown, Jr., MD, MPH

Frank Cardile Professor of Medicine
Chief,
Center for Liver Disease
Columbia University College of Physicians & Surgeons
NewYork-Presbyterian Hospital
New York, New York

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead

Faculty Disclosure

Primary Author

Robert S. Brown, Jr., MD, MPH

Frank Cardile Professor of Medicine
Chief,
Center for Liver Disease
Columbia University College of Physicians & Surgeons
NewYork-Presbyterian Hospital
New York, New York

Robert S. Brown, Jr., MD, MPH, has disclosed that he has received consulting fees from Bristol-Myers Squibb and Gilead Sciences and funds for research support from Gilead Sciences.